MedPath

Evatanepag

Generic Name
Evatanepag
Drug Type
Small Molecule
Chemical Formula
C25H28N2O5S
CAS Number
223488-57-1
Unique Ingredient Identifier
L266R6E31E

Overview

Evatanepag has been used in trials studying the treatment of Tibial Fractures.

Background

Evatanepag has been used in trials studying the treatment of Tibial Fractures.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 2
Completed
Posted: 2007/09/21
Sponsor:Pfizer

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath